| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 9e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |